News Daily News Model Shows Cost-Effectiveness of Renal Denervation in Men, Women L.A. McKeown December 02, 2012
Presentation Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension Presenter: Marc Dorenkamp November 29, 2012
Presentation TCT 2012 Initiating a Renal Denervation Program Presenter: George Dangas October 25, 2012
Presentation TCT 2012 Vincristine Local Delivery for Renal Artery Denervation Presenter: Christodoulos Stefanadis October 24, 2012
Presentation TCT 2012 The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry Presenter: Felix Mahfoud October 24, 2012
Presentation TCT 2012 Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical) Presenter: Vasilios Papademetriou October 24, 2012
Presentation TCT 2012 Lessons Learned Using the Symplicity Catheter 2: Complex Anatomy and Case Selection Presenter: Erwin Blessing October 24, 2012
Presentation TCT 2012 FIM Evaluation of a New Spiral Multielectrode RF Catheter (Medtronic) Presenter: Martin Rothman October 24, 2012
Presentation TCT 2012 Extravascular Renal Denervation (Ablative Solutions) Presenter: Tim Fischell October 24, 2012
Presentation TCT 2012 What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data Presenter: Deepak Bhatt October 24, 2012
Presentation TCT 2012 Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy Presenter: Renu Virmani October 24, 2012
Presentation TCT 2012 Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us Presenter: Michael Bohm October 24, 2012
Presentation TCT 2012 SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design! Presenter: Darrel Francis October 24, 2012
Presentation TCT 2012 Sham Trials Are Burdensome and Introduce Their Own Errors! Presenter: Deepak Bhatt October 24, 2012